1. Home
  2. RES vs VCEL Comparison

RES vs VCEL Comparison

Compare RES & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RPC Inc.

RES

RPC Inc.

HOLD

Current Price

$7.61

Market Cap

1.5B

Sector

Energy

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$34.21

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RES
VCEL
Founded
1984
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
RES
VCEL
Price
$7.61
$34.21
Analyst Decision
Hold
Strong Buy
Analyst Count
5
5
Target Price
$5.64
$57.75
AVG Volume (30 Days)
2.2M
633.8K
Earning Date
05-05-2026
05-08-2026
Dividend Yield
2.15%
N/A
EPS Growth
N/A
60.00
EPS
0.15
0.32
Revenue
$41,919,000,000.00
$276,259,000.00
Revenue This Year
$3.29
$19.40
Revenue Next Year
$4.05
$18.24
P/E Ratio
$49.77
$106.97
Revenue Growth
2216.21
16.45
52 Week Low
$4.18
$28.95
52 Week High
$7.53
$45.97

Technical Indicators

Market Signals
Indicator
RES
VCEL
Relative Strength Index (RSI) 63.68 50.65
Support Level $5.19 $31.24
Resistance Level N/A $34.77
Average True Range (ATR) 0.30 1.25
MACD 0.05 0.11
Stochastic Oscillator 79.22 37.04

Price Performance

Historical Comparison
RES
VCEL

About RES RPC Inc.

RPC Inc is an oilfield services company. It provides specialized oilfield services and equipment to independent and oil and gas companies engaged in the exploration, production, and development of oil and gas properties throughout the United States. Its operating segment includes Technical Services and Support Services. The Technical Services segment, which generates maximum revenue, comprises service lines that generate revenue based on equipment, personnel, or materials at the well site and are closely aligned with completion and production activities of the customers. The Support Services segment comprises service lines that generate revenue from services and equipment offered off the well site and are closely aligned with the customers' drilling activities.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: